XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Considerations (Tables)
9 Months Ended
Mar. 31, 2022
Fair Value Considerations  
Schedule of fair value on a recurring basis

    

Fair Value Measurements at March 31, 2022

    

Fair Value at March 31, 

    

    

    

2022

 

(Level 1)

 

(Level 2)

 

(Level 3)

(In thousands)

Assets:

 

 

Cash and cash equivalents

$

27,613

$

27,613

$

$

Total

$

27,613

 

$

27,613

 

$

$

Liabilities:

Contingent consideration

 

$

371

 

$

 

$

 

$

371

CVR liability

 

720

 

 

 

720

Total

$

1,091

 

$

 

$

$

1,091

    

Fair Value Measurements at June 30, 2021

    

Fair Value at June 30, 

    

    

    

2021

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

(In thousands)

Assets:

Cash and cash equivalents

$

49,649

$

49,649

$

$

Total

$

49,649

 

$

49,649

 

$

$

Liabilities:

Contingent consideration

$

12,057

 

$

 

$

 

$

12,057

CVR liability

1,395

 

 

 

1,395

Total

$

13,452

 

$

 

$

$

13,452

Schedule of changes in Level 3 inputs

    

CVR

    

Contingent

Warrant

Liability

Consideration

Liability

(In thousands)

Balance as of June 30, 2021

 

$

1,395

$

12,057

$

Included in earnings

 

(675)

579

(211)

Purchases, issues, sales and settlements:

 

 

 

Issues

 

 

 

 

590

Settlements*

 

 

 

(12,265)

 

(379)

Balance as of March 31, 2022

 

$

720

$

371

$

Schedule of significant assumptions used in valuation

Significant assumptions used in valuing CVRs were as follows:

March 31, 

    

2022

Leveraged Beta

 

0.79

Market risk premium

6.22

%

Risk-free interest rate

2.12

%

Discount

19.50

%

Company specific discount

 

10.00

%

Significant assumptions used in valuing the warrants were as follows:

January 26,

    

2022

Expected volatility

 

56.75

%

Equivalent term (years)

5.00

Risk-free rate

1.66

%

Dividend yield

0.00

%